Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

The other, the Federal Trade Commission, is already conducting a major investigation of pharmacy benefit managers and is suing over their pricing practices regarding insulin ... three PBMs are the ...

In a study presented at the Summit on Stem Cell Derived Islets in Boston, researchers report on encouraging results using an ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...

The "middlemen of medicine" have become obstacles to progress, often perpetuating inefficiencies and exacerbating healthcare's existing problems.

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

The other, the Federal Trade Commission, is already conducting a major investigation of pharmacy benefit managers and is suing over their pricing practices regarding insulin. She was speaking just ...

FTC sues drug middlemen for allegedly inflating insulin prices Pfizer says drug for deadly cancer condition that causes weight loss shows positive trial data Gilead says its twice-yearly shot cut ...

Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus Monday, one of the country’s top antitrust watchdogs said her agency is ...